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Abstract 
Background: Organised screening programmes often rely on written materials to 
inform the public. In the UK, women invited for cervical cancer screening receive a 
leaflet from the National Health Service (NHS) to support screening decisions. 
However, information about screening may be too complex for people to understand, 
potentially hindering informed decision making. 
Objectives: We DLPHGWRLGHQWLI\ZRPHQ¶VGLIILFXOWLHVLQLQWHUSUHWLQJWKHOHDIOHWXVHG
in England, and negative and positive responses to the leaflet. 
Methods: We used a sequential mixed-methods design involving two steps: 
cognitive think-aloud interviews (n=20), followed by an England-wide survey (n=602). 
Data were collected between June 2017 and December 2018, and participants 
included women aged 25-64 with varying socio-demographics. 
Results: Interview results revealed misunderstandings concerning screening results, 
benefits and additional tests and treatment, although participants tended to react 
positively to numerical information. Participants were often unfamiliar with the 
potential harms associated with screening (i.e., screening risks), key aspects of 
HPV, and complex terms (e.g., dyskaryosis). Survey results indicated that 
interpretation difficulties were common (M correct items= 12.5 out of 23). Lower 
understanding was associated with lower educational level ȕV!ps<.001), lower 
QXPHUDF\VFRUHVȕ p<.001), and non-ZKLWHHWKQLFLW\ȕ p=.007). The 
leaflet overall was evaluated positively. 
Conclusions: Despite previous user testing of the leaflet, key information may be 
too complex for some recipients. As a consequence, they may struggle to make 
informed decisions about screening participation based on the information provided. 
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We discuss implications for the improvement of communications about screening 
and decision support. 
Keywords: cancer screening; cervical cancer; informed decision making; risk 
communication; patient information 
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Cervical cancer is highly preventable and typically caused by the human 
papillomavirus (HPV). HPV infection can cause abnormal changes in cervical cells, 
potentially leading to cancer. The primary aim of cervical screening is to detect 
abnormal cells, which can be removed before becoming cancerous. In the UK, 
population-based cervical screening was implemented in 1988, and has contributed 
to substantial reductions in cervical cancer incidence and cancer-specific 
mortality.[1±5] In 2014, age-standardised incidence was estimated at 11.8 in 
100,000 and age-standardised mortality at 3.3 in 100,000.[6] Recent estimates 
indicate that without screening there would be 1,827 additional cervical cancer 
deaths per year in England.[5]    
 The 8.¶VNational Health Service (NHS) offers free cervical screening every 3 
years to women aged 25-49, and every 5 years to women aged 50-64. Eligible 
women are mailed an invitation letter and a leaflet containing information about 
cervical cancer, its causes, what screening involves, possible results, as well as 
screening benefits and risks. Benefits include reduction of cervical cancer incidence 
and mortality. Risks include potential detection and treatment of abnormal cells that 
would have cleared up on their own [7,8] and increased risk of preterm birth among 
women who are treated to remove abnormal cells.[9±11] Initial screening results are 
communicated by letter, and women invited for further tests (i.e., a colposcopy) 
receive an additional leaflet describing the procedure, possible results, and risks of 
treatment. 
Besides raising awareness of cervical screening, a key aim of the invitation 
leaflet for England is to support informed choices about participation.[12]1 However, 
communications about screening often involve quantitative information that can be 
complex, even for educated audiences.[13,14] Concepts such as overdiagnosis and 
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overtreatment are unfamiliar and counterintuitive to most people.[15,16] Even NHS 
materials that have been user-tested may include complex numerical information or 
terminology.[17] Screening communications that are not well understood may cause 
undue concernUHGXFHUHFLSLHQWV¶EHOLHIVDERXWWKHLUFDSDELOLW\WRSDUWLFLSDWHLQ
screening (i.e., self-efficacy), and undermine informed uptake.[13,18] Individuals with 
lower levels of educational attainment or numeracy may be particularly affected, 
contributing to socioeconomic inequalities in screening participation.[19,20] 
Here we aimed to assess ZRPHQ¶s difficulties in interpreting the NHS cervical 
screening leaflet for England. We also sought to explore ZRPHQ¶V responses to the 
leaflet, including its numerical information and infographics. These aims were of 
relevance because the leaflet was being revised to reflect the move to HPV primary 
screening in England, whereby samples will first be tested for HPV.[21] A better 
understanding of weaknesses and strengths of the current leaflet can help to inform 
new versions, and point to specific aspects requiring attention. 
We used a sequential mixed-methods design involving two steps.[22,23] First, 
qualitative cognitive think-aloud interviews aimed to identify women¶VUHVSRQVHVWR
and potential difficulties with the leaflet. Second, a quantitative survey aimed to 
examine the generalizability of interview findings by assessing the prevalence of 
difficulties and responses in the population. The survey also explored whether 
difficulties and responses varied with participant characteristics, including socio-
demographics, screening experience, and numeracy. Participants in both steps were 
recruited from England, because the leaflet we tested focused on England. Ethical 
approval for both steps was obtained from the ethics committee of the University of 
Leeds (AREA 16-071 and AREA 17-002). All materials and survey data are available 
from the Open Science Framework (https://doi.org/10.17605/OSF.IO/8WQZV).[24] 
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Step 1 Methods: Cognitive Think-Aloud Interviews 
In cognitive think-aloud interviews, women were asked to vocalize their 
thoughts while reading the leaflet. This method provides access to the cognitive 
processes that occur during a task and is often used to identify potential usability 
problems.[17,25,26]  
Participants. 
 Women were recruited in June 2017 via Luto Research Ltd. in Leeds, 
England. Our sample size (n=20) was based on related think-aloud research[17] and 
evidence that 10-15 interviews are typically enough to identify most usability issues 
or themes.[27,28] Four pilot interviews were undertaken before the main 20. Luto 
telephoned potential participants from their database. Women were eligible if they 
were aged 25-64 and had not had cervical cancer. Purposive sampling ensured 
diversity in age and education. Following /XWR¶Vstandard procedures, we excluded 
people taking medication for opioid addiction (due to potentially impaired cognitive 
function), current or retired healthcare professionals, and others routinely working 
with medical information. 
Leaflet. 
 Participants received the leaflet entitled µNHS cervical screening: Helping you 
GHFLGH¶0D\YHUVLRQ, which is available from 
https://www.webarchive.org.uk/wayback/en/archive/20170407074808/https://www.go
v.uk/government/publications/cervical-screening-description-in-brief 
Procedure. 
Interviews were conducted in university meeting rooms by the first author. 
After giving informed consent, participants received standardized instructions about 
the think-aloud task. :HXVHGDµPDUNHGSURWRFRO¶that instructed participants to read 
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out the leaflet and think aloud every time they encountered a red asterisk in the text. 
Asterisks were placed at the end of bullet points, short paragraphs (i.e., two short 
sentences), and long sentences (i.e., more than 25 words).[17,25].2 
Following recommended procedures, participants first practiced with a leaflet 
about an unrelated topic.[26] After three successful utterances, they received the 
cervical screening leaflet. Following the think aloud task, participants answered 
questions about the leaflet, including how much they liked it, its numerical 
information, and the infographic of possible screening results (Figure 1a). Finally, 
they completed a questionnaire assessing participant characteristics, including 
cervical screening experience, previous abnormal results, knowledge of someone 
diagnosed with cervical cancer, first language (English or other), and ethnicity (Table 
1). Participants also completed 6FKZDUW]HWDO¶V3-item numeracy measure [14], 
which can provide good discriminability in samples of the general population. Details 
on age, education, and employment status were obtained from Luto. 
Analysis. 
Interviews were audio-recorded, transcribed verbatim, and analysed in QSR 
NVivo12. We used thematic analysis²a qualitative approach for identifying relevant 
patterns of meaning, independently of quantifiable frequency measures.[29±31] All 
transcripts were read by two researchers (YO and DP). YO generated initial codes 
and searched for initial themes and subthemes. YO and DP reviewed themes and 
subthemes as needed and agreed on definitions and names. The thematic map was 
discussed iteratively with the remaining authors, who indicated whether the themes 
were adequately represented by the quotes and suggested alternative themes where 
relevant, until a final thematic map was defined.[17]3  
<Figures 1a and 1b> 
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Step 1 Results 
Sample characteristics. 
The sample (n=20) was diverse in age, educational level, and numeracy, 
though all participants were of white ethnicity and had previously participated in 
cervical screening (Table 1). 
<Table 1> 
Themes. 
 We identified six themes: two reflecting difficulties in interpretation, two 
reflecting negative reactions, and two reflecting positive reactions. Illustrative quotes 
are provided in Box 1. 
<Box 1> 
Misunderstandings and self-reported confusion. This theme reflects 
aspects of the leaflet that were either not interpreted as intended or resulted in 
confusion. It included three subthemes: 
Screening results. Numerical information about possible screening results 
caused confusion. For instance, the leaflet states that out of 100 women who have 
cervical screening, about 94 will have a normal result, 6 will have abnormal cells, 
DQGZLOOEHLQYLWHGIRUDFROSRVFRS\7KHOHDIOHWIXUWKHUVWDWHVWKDW³DERut half the 
women who have colposcopy are found to have abnormal cells that need to be 
UHPRYHG´7Kus, the leaflet implies that about 2 in 100 women will need treatment for 
abnormal cells. Instead, participants appeared to infer that half of the women who 
have screening may have abnormal cells. 
Screening benefits. Participants also misunderstood numerical information 
about screening benefits. Specifically, the leaflet explains the reduction in the risk of 
JHWWLQJFHUYLFDOFDQFHUE\VWDWLQJ³VFUHHQLQJVWRSV about 1 woman getting cervical 
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FDQFHUIRUHYHU\ZRPHQZKRKDYHVFUHHQLQJ´Some participants incorrectly 
inferred that this implies that 1 out every 100 women who have screening will be 
diagnosed with cancer.  
Additional tests and treatment. Participants expressed confusion about the 
purpose of additional tests and when these may be offered. The leaflet explains that 
if slightly abnormal cells are detected, the sample will be tested for the HPV types 
that can cause cervical cancer. Some participants incorrectly inferred that samples 
would be tested for cancer if abnormal cells are detected. Others incorrectly inferred 
that treatment for abnormal cells is offered to women who test positive for HPV or 
abnormal cells, independently of colposcopy results.  
Knowledge gaps and unfamiliar concepts. This theme focuses on 
concepts that were unfamiliar to participants, and in some cases were seen as 
concerning or scary. Participants often noted that additional clarifications about these 
concepts would be useful. This theme included four subthemes: 
HPV. Participants often noted that they were not previously aware of HPV, its 
link to cervical cancer, how it is transmitted, or the fact that it can regress without 
treatment. Some participants wondered how HPV might affect men. 
Screening risks. Some participants expressed concern about the risk of 
premature labour associated with treatment for abnormal cells, and noted that it 
would be good to quantify the risk. 
Complex terms (colposcopy, dyskaryosis). Participants often struggled to 
pronounce these terms, and highlighted their complexity. Some questioned what a 
colposcopy would involve and whether it would hurt, particularly after reading initial 
sections of the leaflet about this. 
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 Smear test (vs. cervical screening). Some participants noted that they were 
PRUHIDPLOLDUZLWKWKHWHUPµVPHDUWHVW¶WRGHVFULEHFHUYLFDOVFUHHQLQJ 
 Concern about speculum and pain. Participants noted that the procedure 
might be uncomfortable or painful. Some mentioned their own unpleasant 
experiences with the speculum. Several also found the image of how the speculum 
is inserted off-putting (Figure 1b). 
 Disagreement screening eligibility and frequency. Participants generally 
questioned the current age range for screening, and felt that screening should start 
earlier or end later. Some also noted that screening should be more frequent. 
3DUWLFLSDQWV¶ Yiews on these issues were generally strong, despite a seemingly 
limited awareness of the rationale behind the current recommendations. 
 Positive reactions to statistical information about screening results and 
screening benefits. Despite some misunderstandings, participants tended to react 
positively to statistical information about screening benefits. For instance, the leaflet 
also mentions cervical screening saves 5,000 lives from cervical cancer a year in the 
UK. This information was often viewed as encouraging.  Participants noted that it 
highlighted the importance of screening. Additionally, information about screening 
results was often viewed as reassuring. 
 Liking of information about the procedure. Participants noted that the 
information about the procedure and specific advice on how to prepare for the test 
was useful. They emphasized that it was good to be informed of the expected length 
of the appointment, waiting time to receive initial results, and of the option to ask that 
a woman performs the test. 
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Leaflet evaluations. 
 The leaflet was evaluated positively, with a mean rating of 5.9 (SD=1.0) on a 
1-7 scale. Evaluations were also often positive for the numeric information (M=5.8, 
SD=1.5) and the infographic showing screening results (M=6.1, SD=1.3)  
Step 2 Methods: Survey 
Participants. 
Survey respondents were recruited through research company Norstat in 
December 2018. Norstat emailed invitations to potentially eligible individuals in their 
database who could speak English to a native standard. Women were eligible if they 
were aged 25-64, lived in England, and had not had cervical cancer or a 
hysterectomy.[32,33] We excluded those who reported being registered with a GP in 
a location where HPV primary screening was piloted at the time, because that 
experience could potentially interfere with interpretations of the leaflet (see 
Supplement Table S1, for a list of pilot sites). We set quotas for age, education and 
ethnicity taking into account distributions in the target population of English women 
aged 25-64 (Supplement, Table S2). The survey was first piloted with 20 
participants. The target sample size for the main survey (n=601) was set to estimate 
prevalence in the target population (n= 14,133,497)[34], with a confidence level of 
95% and a margin of error of 4%. Following standard practice, Norstat overrecruited 
to meet the target sample size after removing inattentive participants who completed 
the survey in less than half of the median completion time (median time=18 min 11s). 
Leaflet. 
The leaflet was the same as in step 1, with the exception that we removed 
three sections that were not linked to interpretation difficulties in step 1 to avoid 
excessive respondent burden: (1) the procedure and specific advice on how to 
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prepare; (2) the symptoms of cervical cancer; and (3) storage of samples after 
screening. 
Survey items. 
 Items assessing interpretations were built on the first two themes identified in 
step 1. We also developed items for each of the remaining themes, except for the 
sixth theme (i.e., liking of information about the procedure), as the corresponding 
information was removed from the leaflet (see above). 
Interpretations. We developed items for each subtheme under 
µmisunderstanding and self-UHSRUWHGFRQIXVLRQ¶DQGµknowledge gaps and unfamiliar 
concepts¶ (Table 3). We also developed items assessing understanding of other 
aspects relevant for screening decisions, including additional screening risks 
(overtreatment, false positives, false negatives) and the main goal of cervical 
screening.[35±37] Items were pre-tested iteratively using three rounds of cognitive 
interviews conducted by the first author (n=4 per round, 12 in total). Participants 
thought aloud while answering each item and were probed for further details where 
relevant. They also suggested alternative wording for items that were unclear or 
confusing.[38] Following each pilot round, items were revised with all authors to 
reduce reading barriers and ensure that they were interpreted as intended. The final 
set of items included 19 true/false items (10 true and 9 false) and 4 open-ended 
items.4 Participants expressed their confidence in their answers on a scale ranging 
from 50% (just guessing) to 100% (absolutely sure).[42] 
Evaluations of image depicting speculum. We assessed evaluations of this 
image (Figure 1b) in relation WRWKHWKHPHµconcern speculum inserted and pain¶:e 
adapted 3 items from previous work[43] (e.g., µHow much do you like or dislike this 
image?¶) using a response scale from 1 to 7 (e.g., 1=do not like it at all, 7=like it a 
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lot). We averaged across items to produce an overall evaluation VFRUH&URQEDFK¶V
Į ). We also asked participants to indicate how the image affected their 
motivation to attend screening when next invited using three response options: µLW
GHFUHDVHVLQFUHDVHVGRHVQRWDIIHFWP\PRWLYDWLRQ¶ 
Views on screening eligibility and frequency. We developed 3 items 
assessing views on the current starting age, ending age, and frequency HJµ,WKLQN
VFUHHQLQJVKRXOGVWDUW«$W%HIRUH$IWHU¶. Participants who expressed 
disagreement with current policy (e.g., who selected µBefore 25¶) were also asked to 
VSHFLI\WKHLUSUHIHUHQFHHJµAt what age do you thinNVFUHHQLQJVKRXOGVWDUW"¶ 
Evaluations of infographic depicting screening results. We assessed 
evaluations of this infographic (Figure 1a) in relation to the theme µpositive reactions 
to statistical information about screening results and screening benefits¶. Items were 
analogous to those assessing evaluations of the image depicting the speculum, 
described above (&URQEDFK¶VĮ ). Participants also indicated how the infographic 
affected their motivation to attend screening. 
Overall leaflet evaluations and familiarity. We developed 3 items to assess 
overall evaluations of the leaflet &URQEDFK¶VĮ . Additionally, we included an 
LWHPWRDVVHVVSDUWLFLSDQWV¶IDPLOLarity with the leaflet (i.e., whether they had read it 
before).[44] Results for all individual evaluation items in the survey are presented in 
the Supplement (Table S3). 
Procedure. 
The survey was implemented in Qualtrics. Participants first read an online 
consent form. Those who agreed to proceed were then presented with questions 
assessing eligibility. In addition to the socio-demographics recorded in step 1, step 2 
also assessed SDUWLFLSDQWV¶VRFLDOJUDGHDFFRUGLQJ to the National Readership 
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Survey system.[45] Categories represented the occupation of the chief income 
earner of the household (Table 1). Next, participants viewed the leaflet and 
answered items assessing interpretations. The different pages of the leaflet 
appeared on separate screens, accompanied by the corresponding interpretation 
items immediately below. Next, they completed items assessing leaflet evaluations, 
familiarity with the leaflet, and views on screening eligibility and frequency. They 
were then presented with the image depicting the speculum, the infographic showing 
screening results, and associated items in each case. Finally, they completed 
questions assessing participant characteristics analogous to those in step 1, 
including the same numeracy measure.5  
Analysis. 
 We computed overall accuracy scores for each participant by adding the 
number of correct responses to all items assessing interpretations. Missing 
responses were coded as incorrect. We performed multiple (univariate) linear 
regression analyses to examine whether accuracy scores, mean confidence ratings, 
and leaflet evaluations varied as a function of participant characteristics. Predictors 
consisted of socio-demographics (age, education, ethnicity, and social grade), 
cervical screening experience, numeracy, and English as a first language.6 The 
lowest educational level and social grade were used as the reference class, and age 
and numeracy scores were entered as continuous variables. Analyses were 
conducted using SPSS 23 for Windows. Full regression results are presented below, 
and mean accuracy, confidence and evaluations corresponding to the different levels 
of all predictors are presented in the Supplement (Table S4) 
Interpretations of NHS cervical screening leaflet 16 
 
Step 2 Results 
Sample characteristics. 
The survey was accessed by 1,953 participants, of which 37% were eligible 
(Figure 2). The final sample (n=602) included 12% participants of non-white ethnicity 
and 9% with no screening experience (Table 1). In the population, 14% are non-
white and 11% have no screening experience (Supplement, Table S2). 
<Figure 2> 
Interpretations. 
Participants answered on average 12.5 items correctly out of 23 (SD=3.06; 
range, 5-21), indicating relatively common interpretation difficulties. Regression 
results revealed that the strongest predictor of accuracy was numeracy, followed by 
education (Table 2). Scores were higher among participants with A-levels and higher 
education, relative to those with GCSE/O level grade or less. Accuracy was also 
higher among whites than among non-whites, and among participants from social 
grades C1 and C2, relative to those from the lowest grades (D and E). 
<Table 2> 
Analyses of individual items revealed that performance was particularly poor 
for items assessing screening results (Table 3). Only 10% of participants accurately 
estimated the number of women expected to have possible cancer cells, and only 
15% accurately estimated the number expected to need treatment for abnormal 
cells. Inspection of the distribution of responses revealed that participants often 
overestimated the likelihood of these adverse results (Supplement, Tables S5a-c; 
Figure S1). For instance, 32% of participants inferred that 40 in 1,000 women would 
have possible cancer cells (correct answer=1 in 1,000), and 19% inferred that 500 in 
1,000 women who have screening would need treatment for abnormal cells (correct 
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answer=20 in 1,000). A different pattern emerged for the item concerning the number 
of women expected to have an abnormal result, where 43% of estimates were 
accurate, and 48% were lower than the correct answer (=60 in 1,000). The fact that 
the correct answer for this item is higher than that of the previous two items implies 
that there was more room for underestimation. Additionally, some incorrect 
responses likely reflect a failure to transform the estimate provided in the leaflet as 
required by the question. Whereas the leaflet stated that 6 out of 100 women will 
have an abnormal result, participants had to indicate how many out of 1,000 would 
have an abnormal result. The most common incorrect response (seen in 31% of 
participants) was 6, which likely reflects direct extraction of the information from the 
leaflet.  
Performance was also poor for items assessing understanding of additional 
tests and treatment. The most common misunderstandings were that treatment 
would be offered to women with abnormal cells (70% of participants) or those who 
test positive for HPV (57%). Instead, the leaflet explains that a colposcopy is offered 
in both cases to determine whether treatment is needed. 
Information about screening benefits and risks was also misunderstood 
frequently, though performance varied substantially across individual items. Whereas 
most participants (94%) understood the concept that screening lowers the risk of 
getting cervical cancer, two thirds (67%) misinterpreted the risk reduction information 
provided µscreening stops about 1 woman getting cervical cancer for every 100 
ZRPHQZKRKDYHVFUHHQLQJ¶. Only 35% of participants accurately estimated the 
effect of screening on the risk of getting cervical cancer, with 18% assuming that the 
risk would be equal in groups of unscreened vs. screened individuals (Supplement, 
Table S5d). Moreover, 26% of participants assumed that the main goal of cervical 
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screening was diagnosis rather than prevention. Concerning screening risks, one of 
the most common misunderstandings was that the screening test itself increased risk 
of premature labour (75% of participants). Additionally, 76% was unaware of the 
possibility of false negative results, and 47% did not understand that screening can 
lead to unnecessary treatment. 
Specific aspects of HPV were also misinterpreted. Although most participants 
(91%) understood that HPV can be passed on during sexual intercourse, 50% of 
them incorrectly inferred that condoms do not lower the risk of infection. More than 
half (57%) DOVRIDLOHGWRXQGHUVWDQGWKDW+39XVXDOO\GRHVQ¶WQHHGDQ\WUHDWPHQW 
<Table 3> 
Self-reported confidence. 
Despite SDUWLFLSDQWV¶ misunderstandings, their self-reported confidence was 
relatively high (Table 3). Mean confidence ranged between 73.9 and 90.1 for items 
assessing screening results and additional tests and treatment, despite poor 
performance. Mean confidence ratings across all items were weakly correlated with 
the total number of accurate responses (r=.21, p< .001), suggesting that participants 
who had better understanding tended to express more confidence. Regression 
results revealed that confidence ratings were higher among more numerate 
participants, and among those with higher education, relative to those with GCSE/O 
levels or less. Confidence was also higher among participants from social grades C1 
and C2, relative to those from the lowest grades (D and E). Older age and cervical 
screening experience were also associated with higher confidence.  
Image depicting speculum. 
 This image was on average evaluated positively, with a mean rating of 5.2 
(SD=1.3) on a 1-7 scale. The majority of participants (72%) noted that their 
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motivation to attend screening would not be affected by this image, though 14% 
noted that it would decrease their motivation, with the remaining 14% saying that it 
would increase it.  
Screening eligibility and frequency. 
 Agreement with the current screening starting age (i.e., 25) and ending age 
(i.e., 64) was low (24% and 33% of participants, respectively). The majority of 
participants (72%) indicated that screening should start before 25, of which 43% 
noted that it should start at 18. The majority (64%) also indicated that screening 
should end after 64, of which 47% stated that it should end at 70. Additionally, 35% 
participants indicated that screening should be offered more frequently, although 
62% agreed with the current screening interval. 
Infographic showing screening results. 
 The infographic received very positive evaluations, with an average rating of 
6.0 (SD=1.1) on a 1-7 scale. A total of 31% participants noted that the infographic 
would increase their motivation to attend screening, with only 2% saying that it would 
decrease it. 
Overall evaluations of the leaflet and familiarity. 
 The leaflet overall was also evaluated positively, with a mean rating of 5.8 
(SD=1.1) out of 7. The regression predicting evaluations explained a small amount of 
variance (Table 2). Participants who had cervical screening experience and whose 
first language was English evaluated the leaflet more positively. The majority of 
participants (64%) reported having read at least some of the leaflet the last time they 
were invited for screening, although 18% reported not having read it, and the 
remaining 18% did not remember previously seeing a leaflet. 
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Discussion 
Our findings suggest that the NHS leaflet about cervical screening may be too 
complex for some recipients. Even though the leaflet underwent extensive user 
testing[12] and was evaluated positively in our study, we documented common 
misunderstandings about key aspects, including screening benefits, risks, and 
results. Despite these misunderstandings, participants¶VHOI-reported confidence in 
their answers was relatively high. This echoes previous findings on overconfidence 
in RQH¶VRZQ knowledge [42,46,47] (but see Olsson [48]). We also found that leaflet 
interpretations were less accurate among participants with lower education, lower 
numeracy, and ethnic minorities. These findings suggest that some recipients may 
struggle to make informed decisions about screening participation based on the 
information provided, and highlight the challenges in developing communications 
that are effective for diverse audiences. 
 In addition to hindering informed decision making, specific misunderstandings 
may have other unintended effects. Although information about screening results 
was often viewed as reassuring by interviewees, survey respondents overestimated 
the likelihood of some adverse results. Relatedly, about a quarter of survey 
respondents failed to understand the preventive purpose of cervical screening, 
converging with recent findings.[49] Misunderstanding of the main goal of cervical 
screening coupled with overestimations of adverse results may lead to undue worry 
about what the test might find. This in turn may potentially lead to avoidance of 
screening, particularly among women with high cancer fear.[49,50] The 
misunderstanding that the screening test increases the risk of preterm labour could 
have a similar effect, particularly among women planning to get pregnant. On the 
other hand, we also found that almost half of the respondents failed to infer that 
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cervical screening can lead to unnecessary treatment. The failure to understand the 
risk of overtreatment may lead to a more positive attitude about screening, at the 
expense of informed decision making. 
 Despite SDUWLFLSDQWV¶misunderstandings, they evaluated statistical information 
relatively positively. Indeed, there is evidence that numbers are often trusted and 
preferred over verbal quantifiers alone to communicate health risks.[51±53] The 
finding that the infographic showing screening results was evaluated positively also 
converges with research showing that simple visual aids are often liked by diverse 
audiences.[54,55] However, our findings also suggest that it may be beneficial to 
consider alternative numerical formats to support understanding. For instance, the 
leaflet did not provide information about the risks of developing cervical cancer and 
dying of cervical cancer with and without screening, contrasting with 
recommendations from the risk communication literature, and International Patient 
Decision Aids Standards.[56] Such information could be communicated in an 
accessible way using fact boxes and/or visual aids[57±59], which could facilitate 
evaluations of the effectiveness of screening. It could also be beneficial to add 
numerical estimates about screening risks, which are currently lacking in the leaflet. 
The use of verbal quantifiers without numbers to express risks is generally 
discouraged as this can lead to diverse interpretations, including overestimations of 
risk.[60±62]  
 Our findings also show that unfamiliar concepts may not be fully understood 
based on the information in the leaflet. Misunderstandings about HPV are of 
particular concern considering the move to HPV primary screening. Our findings 
support work that has identified similar gaps in HPV knowledge[63,64], and provide 
the first evidence that some misunderstandings may persist despite the explanations 
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provided in the leaflet. Hence, our findings highlight the importance of further 
clarifying key aspects of HPV, such as its link with cervical cancer, transmission, and 
how it can clear without treatment. Additionally, the leaflet could potentially be 
simplified by removing other unfamiliar concepts that are arguably not essential for 
informed screening decisions at the invitation stageVXFKDV³G\VNDU\RVLV´RU 
specific aspects concerning colposcopies. Simplifying communication materials can 
increase understanding among diverse audiences without negatively affecting 
evaluations or intentions to participate in the advertised programmes.[65] 
Limitations and future research 
Our work has limitations. First, the marked think-aloud procedure may have 
introduced some bias as it encouraged comments at specific points in the text. 
Although prompts to think aloud were very frequent, they may have focused 
participants more on aspects immediately preceding each prompt. Second, our 
survey sample was recruited from an online panel, which may not have been 
representative of the population. Although we used quotas considering distributions 
of key demographics in the population, we were unable to recruit enough participants 
with no qualifications (8% in our sample, vs. 16% in the population; Supplement, 
Table S2). Relatedly, all think-aloud interviewees had previously participated in 
cervical screening at some point, which may have facilitated interpretations of 
information they could relate to their own experience. Some of this information (e.g., 
details about the procedure) was not tested in the survey because interviewees 
showed no confusion. Previous screening experience could potentially also result in 
more positive reactions to such information. 
Third, although we took measures to remove inattentive survey participants, 
others may not have read the leaflet carefully either. However, any 
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misunderstandings attributable to inattention may be present among actual leaflet 
recipients, who often do not read the full leaflet.[46] Additionally, it is also possible 
that performance was negatively affected by specific item wordings. Although we 
pre-tested all items, some may have not been interpreted as intended. For instance, 
the item concerning the risk of preterm labour may have been interpreted by some 
as referring to screening participation generally, rather than to the screening test 
itself. Relatedly, the item assessing estimates of the cervical cancer risk reduction 
associated with screening did not provide a time interval (e.g., lifetime risk). While a 
time interval was also lacking in the leaflet, this may have contributed to 
interpretation difficulties. The chances of correct responses due to guessing should 
also be considered when interpreting our results. The high confidence ratings 
suggest that participants did not report guessing in most cases. However, some may 
have been reluctant to admit doing so. 
Future work could examine the impact of cultural differences and prior beliefs 
about cancer or screening on interpretations of cervical screening communications. 
Previous beliefs about the effectiveness of screening in general or strong fears from 
cancer could interfere with comprehension or its relationship with screening 
intentions.[58,66] Similarly, low perceived cancer risk or cancer fatalism (e.g., the 
belief that cancer is incurable) could bias processing of information about screening, 
leading to misinterpretations. Such beliefs are more prevalent among ethnic 
minorities than among white British women, independently of other socio-
demographic factors.[67,68] This could help to explain our finding that non-white 
ethnicity was linked with lower leaflet understanding after controlling for other socio-
demographics and native language. 
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Conclusions 
Our work points to strengths and weaknesses in the NHS cervical screening 
leaflet for England, which constitutes a central communication tool of the screening 
programme. Addressing the weaknesses may contribute to reduce screening 
inequalities, and support understanding for wider audiences. While we focused on 
the leaflet for England, our findings are also relevant for the design of other leaflets 
such as the Scottish leaflet, which will be revised to reflect the move to HPV primary 
screening in 2019/20. Our findings also have implications for improving other 
communications about cervical screening (e.g., websites), as well as potentially 
about other screening programmes internationally. 
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Footnotes 
1
 Each of the four countries of the UK²England, Scotland, Wales and Northern 
Ireland²has its own leaflet. Specific content varies across leaflets. Here we focused 
on the leaflet for England. 
2
 Marked protocols encourage reports of misunderstandings and confusion that may 
otherwise go unnoticed [25], and have previously been used to examine 
comprehension of patient information leaflets.[17] This procedure also proved more 
effective in our pilot interviews than unmarked protocols. 
3
 This process reflects an established thematic analysis procedure involving six 
iterative phases:[31] (1) familiarisation with the data, including repeated reading and 
noting initial ideas, (2) generating initial codes by systematically identifying patterns, 
(3) searching for themes by combining the initial codes into potential themes and 
subthemes (i.e., specific topics within a theme), (4) reviewing themes by checking 
that the coded quotes form a coherent pattern and that the thematic map reflects the 
meanings in the whole data set, (5) defining and naming themes, and (6) final 
analysis and write-up. 
4
 We used the true/false format for three reasons. First, true/false items do not 
require considering multiple alternatives at a time, and hence are less cognitively 
demanding than multiple-choice items.[39] Second, true/false items are less likely to 
artificially increase the scores of test-wise respondents, who may use cues in the set 
of answer options in multiple-choice items (e.g., excess specificity of some options, 
length, or order of options) [40]. Third, true/false items can help to detect instances 
of mixed or partial understanding of a given concept [41]. 
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5
 The survey also included an alternative image depicting the speculum and items 
unrelated to the current research questions (i.e., perceptions of the risk of developing 
cervical cancer and screening intentions), which will be reported elsewhere. 
6
 We did not include previous abnormal results as a predictor because this question 
was only answered by participants who reported having screening experience. Due 
to an error in survey flow, this was also the case for the item assessing knowledge of 
someone diagnosed with cervical cancer, which was also not included as a predictor. 
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Table 1. Participant characteristics 
 Interviews, Step 1 
(n=20) 
Survey, Step 2a 
(n=602) 
 n (%) n (%) 
Age   
25-34 5 (25) 152 (25.2) 
35-44 5 (25) 154 (25.6) 
45-54 5 (25) 163 (27.1) 
55-64 5 (25) 133 (22.1) 
Mean age (standard deviation), range 44.8 (11.6), 26-62 44.4 (10.9), 25-64 
Education   
*&6(2Oevel grade or equivalent 8 (40) 294 (48.8) 
A-levels or equivalent 8 (40) 90 (15.0) 
Higher education or equivalent 4 (20) 218 (36.2) 
Ethnicity    
White 20 (100) 532 (88.4) 
Non-white 0 (0) 70 (11.6) 
Social gradeb   
AB (managerial/professional) - 136 (22.6) 
C1C2 (supervisory/skilled manual) - 268 (44.5) 
DE (semi-skilled and unskilled manual/casual 
and lowest grade workers/ unemployed) 
- 198 (32.9) 
First language   
English 20 (100) 543 (90.2) 
Other 0 (0) 59 (9.8) 
Numeracyc   
Score = 0 7 (35) 92 (15.3) 
Score = 1 2 (10) 180 (29.9) 
Score = 2 5 (25) 213 (35.4) 
Score = 3 6 (30) 117 (19.4) 
Mean score (standard deviation), range 1.5 (1.3), 0-3 1.6 (1.0), 0-3 
Cervical screening experience   
Yesd 20 (100) 545 (90.5) 
No 0 (0) 53 (8.8) 
Previous abnormal resulte   
Yes 7 (35) 145 (24.1) 
No 13 (65) 389 (64.6) 
Know someone diagnosed with cervical cancere   
Yes 5 (25) 102 (16.9) 
No 15 (75) 426 (70.8) 
Note: asample sizes vary due to missing data, percentages are calculated considering 
the total number of participants; b employment status but not social grade was recorded 
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in step 1 (n=14 employed; n=2 unemployed or students, n=2 retired); c numeracy was 
assessed using the measure by Schwartz et al.[14] (skew step 1: ±.08; step 2: ±.12); d 
includes n=5 who were overdue for screening in step 1 and n=110 in step 2; e In step 2 
these questions were only displayed to participants who previously reported having 
screening experience 
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Table 2. Linear regression models predicting accuracy of interpretations, self-reported confidence, and overall leaflet evaluations 
 Accuracy of interpretations 
(0-23) 
Self-reported confidence 
(50-100) 
Leaflet evaluations 
(1-7) 
 
B (SE) ȕ p B (SE) ȕ p B (SE) ȕ p 
          
Age .01 (.01) .04 .317 .10 (.04) .11 .006 -.00 (.00) -.03 .462 
Education          
GCSE/O level grade or less vs. A-levels 1.25 (.35) .15 .000 2.33 (1.23) .08 .059 -.05 (.14) -.02 .705 
GCSE/O level grade or less vs. Higher education 1.27 (.29) .20 .000 2.90 (1.01) .14 .004 -.03 (.11) -.01 .788 
Ethnicity (1=White; 0=Non-white) .98 (.36) .10 .007 .85 (1.29) .03 .509 .02 (.14) .01 .878 
Social grade          
DE (semi-skilled/unskilled/unemployed) vs. AB 
(managerial/professional) 
.44 (.34) .06 .197 1.96 (1.22) .08 .107 .22 (.13) .09 .109 
DE (semi-skilled/unskilled/unemployed) vs. C1C2 
(supervisory/skilled manual) 
.54 (.27) .09 .044 2.51 (.95) .13 .009 .14 (.11) .07 .173 
First language (1=English; 0=other) -.34 (.40) -.03 .387 .87 (1.40) .03 .536 .33 (.16) .09 .036 
Numeracy  1.13 (.12) .36 .000 1.39 (.32) .14 .001 .00 (.05) .00 .998 
Cervical screening experience (1=Yes; 0=No) -.42 (.40) -.04 .288 3.46 (1.42) .10 .015 .52 (.16) .14 .001 
Model statistics 
R2=.25 
F(9,588)= 21.66, p < .001 
R2=.10 
F(9,588)= 7.38, p < .001 
R2=.03 
F(9,588)= 2.19, p = .021 
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Table 3. Survey results for items assessing interpretation 
Item % 
correct 
M 
confid. 
Screening results 
Imagine 1,000 women who have cervical screening. About how 
PDQ\RIWKHPZLOO« 
  
Have an abnormal result? (60) 43.2 90.1 
Need treatment to remove abnormal cells? (20) 15.3 73.9 
Have cells that could be cancer? (1) 10.3 82.7 
Additional tests and treatment    
If a woman has slightly abnormal cells, her sample gets tested 
for cancer next. (F) 
46.2 87.6 
If a woman has HPV, she is offered treatment to prevent cancer. 
(F) 
41.4 83.8 
If a woman has very abnormal cells, she is offered treatment to 
prevent cancer. (F) 
30.4 86.7 
Screening benefits and main goal of cervical screening   
Cervical screening prevents as many as 5,000 cervical cancer 
deaths each year in the UK. (T) 
96.7 91.3 
Cervical screening lowers the risk of getting cervical cancer. 94.4 93.9 
The main goal of cervical screening is to find cancer that is 
already there. (F) 
73.6 89.9 
Among 1,000 women who do not have cervical screening, about 
20 will get cervical cancer. Now imagine 1,000 women who do 
have cervical screening. How many do you think will get cervical 
cancer? (10) 
34.7 71.9 
In 1 out 100 women, cervical screening helps to find cancer that 
is already there. (F) 
32.7 86.8 
Screening risks 
A woman who does not have abnormal cells could get an 
abnormal test result. (T) 
69.8 80.4 
Cervical screening can lead to treatment of abnormal cells that is 
not needed. (T) 
53.2 82.6 
Imagine a woman has a cervical screening test. If she gets 
pregnant later, it is slightly more likely that her baby will be born 
early. (F) 
25.1 91.7 
A normal test result rules out that there are any abnormal cells 
(F) 
24.4 84.8 
HPV 
HPV can be passed on during sexual intercourse. (T)a 91.0 92.6 
0HQFDQ¶WJHW+39F)a 72.4 82.1 
HPV is a sexually transmitted infection (STI). (T)  66.4 88.6 
+39XVXDOO\GRHVQ¶WQHHGDQ\WUHDWPHQW (T)a 56.8 85.8 
Using condoms lowers the risk of getting HPV. (T)a 49.8 89.3 
Colposcopy, dyskaryosis   
A colposcopy checks if there are abnormal cells in the cervix. (T) 89.7 91.8 
&HUYLFDOFDQFHUFHOOVDUHNQRZQDV³KLJK-JUDGHG\VNDU\RVLV´) 33.9 81.2 
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Cervical screening (vs. smear tests)   
Cervical screening tests were previously known as smear tests. 99.0 97.5 
Note: Correct answers (based on the information in the leaflet) are indicated in 
brackets. F=false; T=true;  a Items adapted from the measure of knowledge about 
HPV by Waller et al. [69]. 
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Box 1. Themes identified in think-aloud interviews and illustrative quotes.  
Summary of relevant leaflet sections Example quotes 
Misunderstandings and self-reported confusion: screening results, screening benefits, additional tests & treatment 
About half the women who have a colposcopy are 
found to have abnormal cells that need to be 
removed (p.8) 
³So about half the women have abnormal cells.  Six women have abnormal cells.  
94 women have a normal resuOW1RZGRQ¶WJHWPHZURQJEXWWKDW¶VQRWKDOI
ThaW¶VUHDOO\QRWKDOI7KDW¶VUHDOO\FRQIXVHGPH´(P19, 28 years, A-Level 
qualifications). 
Cervical screening helps prevent cervical cancer. 
It stops about 1 woman getting cervical cancer for 
every 100 women who have screening. (p.9) 
 
³2ND\VR²  Okay.  Because, of course, 96 were²  No.  94 were okay and 6 had 
abnormal, and of that, only one person is likely to get cervical cancer out of the 
ZKROHWKLQJ2ND\WKDWPDNHVDORWRIVHQVH´ (P 10, 45 years, GCSE level 
qualifications). 
Depending on the result of your test, your sample 
may be tested for the types of human 
papillomavirus (HPV) that can cause cervical 
cancer. (p.3) 
³6RLW¶VOHWWLQJPHNQRZWKDWLI\RXKDGDQ\DEQRUPDOFHOOVWKH\ZLOOEHGRLQg a 
sample of the test and testing it to see if you haYHJRWFHUYLFDOFDQFHU´ (P8, 42 
years, GCSE level qualifications). 
Knowledge gaps and unfamiliar concepts: HPV, screening risks (premature labour), colposcopy, dyskaryosis, and cervical 
screening (vs. smear test) 
HPV is found on the skin around the whole genital 
area, and can be spread through any type of 
sexual activity. This means that condoms do not 
always protect you from getting an HPV infection. 
(p.11) 
³,WGRHVQ
WWHOOPHUHDOO\ZKR
VWKHFDUULHr.  Is it the man?  Is it the woman?  I'm not 
sure.  And if it's the man, does he have it for a while?  Does it affect me in any 
way?  If the woman gets cervical cancer, does the man get any kind of cancer 
IURPLW"7HVWLFXODUPD\EH",GRQ
WNQRZ´ (P3, 48 years, GCSE level 
qualifications). 
Women who get pregnant after having abnormal 
cells removed are slightly more likely to have their 
baby 1 to 2 months early. (p.9) 
³0D\EHFRXOGGRZLWKVRPHILJXUHVWKHUHEHFDXVHREYLRXVO\WKDWLVDULVNDQG,
know we have to be informed of risks, but I think that might just need putting into 
context a little bit, the numbers´3\HDUV$-Level qualifications). 
As a next step you may be offered another test ³*RVKVRZKDW
VDFROSRVFRS\":KDWGRHVWKDWWDNH":KDWGRHVWKDWLQYROYH,
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(called a colposcopy) to look at your cervix more 
closely. If the person carrying out the colposcopy 
finds abnormal cells, they will suggest that you 
have the cells removed, usually during another 
colposcopy. (p.3) 
would wonder.  And the thought is, you may have to have it done twice.  Quite a 
VFDU\WKRXJKWPD\EH´(P10, 45 years, GCSE level qualifications). 
A few women will have very abnormal cells in their 
sample. This is called high-grade dyskaryosis. If 
you have very abnormal cells, you will offered a 
colposcopy to check your cervix more closely. 
(p.6) 
³,¶GOLNHWRNQRZZKDWWKDWLVEHFDXVHLW¶VVD\LQJYHU\DEQRUPDOFHOOVDQGLW¶VDELW
VFDU\DQGHVSHFLDOO\XVLQJELJPDVVLYHZRUGVOLNHWKHILUVWWKLQJ\RX¶UHJRLQJWR
do is gRRQWKHLQWHUQHWDQGOLNHORRNLWXSVRLW¶GEHQLFH WKDWLW¶VLQWKHUHZLWK
WKDW´ (P1, 38 years, A-Level qualifications). 
Cervical screening (which used to be called the 
µVPHDUWHVW¶LQYROYHVWDNLQJDVPDOOVDPSOHRI
cells from the surface of your cervix. (p.3) 
³,WKLQNVPHDUWHVWLVSUREDEO\DEHWWHUZord because people might understand 
thDW:K\QRWNHHSWKHVDPHQDPH"´(P 11, 60 years, Higher educational 
qualifications) 
Concern speculum inserted and pain 
A device called a speculum will be put into your 
vagina and then used to open it gently. This allows 
the nurse or doctor to see your cervix. (p.4) 
 
³,GRQ¶WNQRZZKHWKHUDOOWKHVSHFXOXPVQRZDUHSODVWLFEXW,WKLQNZKHQ,ILUVWKDG
one it was a metal one and it was horrible.  So I think it might be useful to put in 
WKHUHLILW¶VDOZD\VJRLQJWREHSODVWLFVSHFXOXPVQRZ´ (P7, 34 years, Higher 
educational qualifications). 
See Figure 1b (image depicting speculum) (p.5) ³7KDWGRHVORRNSDLQIXOWRPHHYHQWKRXJKWKH\¶UHVD\LQJLW¶VQRWWKDWORRNV
horrible.  It looks like a medieval torture device!  (LDXJKV1R,GRQ¶WOLNHWKDW´ 
(P6, 40 years, Higher educational qualifications). 
Disagreement screening eligibility and frequency 
The NHS offers cervical screening to all women 
aged 25 to 49 every 3 years and to all women 
aged 50 to 64 every 5 years. This is because most 
cervical cancers develop in women aged 25 to 64. 
(p.1) 
³,NQRZWRPHLWMXVWVFUHDPVOLNHZHOOLW
VMXVWFRVWFXWWLQJUHDOO\EHFDXVHLW
VMXVW
saying most happen in those age groups.  But I think there could be a potential to 
save more if it wasn't just restricted to thosHDJHV´ (P13, 51 years, A-Level 
qualifications). 
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If you do not have an HPV infection, you have a 
low risk of developing cervical cancer before your 
next screening test. So you will be invited back for 
screening again in 3 or 5 years depending on your 
age, as usual. (p.6) 
 
,VWLOOWKLQNLW¶VWRRORQJ,WVKRXOGEHOHVVWKDQWKUHH\HDUVDQGILYH\HDUV,WKLQN
HYHU\\HDUDQGDKDOIUHDOO\,PHDQ,¶PQRWEHLQJIXQQ\EXWDQH\HWHVW\RX¶UH
called every two years.  This is worse than an eye ± things like that.  It should be 
HYHU\\HDURUHYHU\\HDUDQGDKDOI,GRQ¶WNQRZ´ (P20, 41 years, GCSE level 
qualifications). 
Positive reactions to statistical information about screening results and benefits 
Out of 100 women who have cervical screening, 
about 94 will have a normal result. If you have a 
normal result, you will have a very low risk of 
developing cervical cancer before your next 
screening test. (p.6) 
³6RWKDW¶VJRRGEHFDXVHLWLVVD\LQJWKDWPRVWZRPHQLW¶VLQQRFHQWDQGLW¶VDJRRG
UHVXOWVRWKDW¶V reassuring, you know, the numbers and your chances are it 
VKRXOGEHRND\VRWKDW¶VJRRG´ (P5, 62 years, GCSE level qualifications). 
 
Cervical screening saves as many as 5,000 lives 
from cervical cancer a year in the UK. (p.9) 
³6RLW
VDJRRGSRLQWUHDOly.  It's basically promoting having a screening test, 
basically, because of how many lives it's saved each year.  It'd make me want to 
GHILQLWHO\JRIRUDFHUYLFDOVFUHHQLQJWHVWNQRZLQJWKHIDFWVOLNHWKDW´ (P12, 26 
years, GCSE level qualifications). 
Liking of information about the procedure 
Cervical screening is usually carried out by a 
female nurse or doctor. If you want to make sure a 
woman carries out your test, you can ask for this 
when you make your appointment. (p.4) 
³<HDKWKDW¶VJRRGWRNQRZ  People need to know that, because the worst thing 
that you ± \RXGRQ¶WZDQWWRZDONLQWRDURRPDQGWKHUH¶VDPDQQXUVHWKHUHRUGR
\RXNQRZZKDW,PHDQ´ (P1, 38 years, A-Level qualifications) 
The nurse or doctor will ask you to undress from 
your waist down and lie on a bed with your knees 
bent and apart. (p.4) 
³,WKLQNWKDW
VJRRGLQIRUPDWLRQEHFDXVHLW
VIXOO\H[SODLQLQJHYHU\WKLQJVR\RXFDQ
prepare yourself, knowing what's going to happen when you get there so you're 
not given the unexpected and are a bit scared abouWZKDW
VJRLQJWRKDSSHQ´ 
(P12, 26 years, GCSE level qualifications). 
The actual test takes only a minute or two. The ³,WKLQNWKDW¶VUHDOO\good to mention, because it is only very quick and I think if 
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whole appointment usually takes about 10 
minutes. (p.4) 
\RX¶UHZRUULHGDERXWLW,WKLQN\RXQHHGWRNQRZWKDWLW¶VQRWQHFHVVDULO\JRLQJWR
WDNHDORQJWLPHDWDOOVRWKDW¶VUHDOO\JRRGWRPHQWLRQ´ (P16, 34 years, Higher 
educational qualifications) 
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Figure captions 
Figure 1. Images in the leaflet: (a) Infographic showing possible screening results (b) 
Image depicting how the speculum is inserted. Reprinted with permission from 
Felton Works. Originally published in the leaflet ³NHS cervical screening. Helping 
you decide´, created by Public Health England on behalf of the National Health 
Service. 
Figure 2. Overview of recruitment in step 2 (survey). 
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